<DOC>
	<DOCNO>NCT00714285</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity GSK influenza vaccine candidate compare licensed trivalent influenza vaccine adult .</brief_summary>
	<brief_title>Immunogenicity Safety Study GSK Influenza Vaccine Candidate Adults .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject establish medical history clinical examination enter study . Subjects investigator believe comply requirement protocol enrol study . A male female , include , 18 60 year age time vaccination . Written inform consent obtain subject . If subject female , must nonchildbearing potential , childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month completion vaccination series . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede administration study vaccine , plan use study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within 3 month prior administration vaccine . Administration vaccine foreseen study protocol 30 day vaccination 21 day post vaccination . Confirmed influenza infection within year precede study start . Administration influenza vaccine Northern Hemisphere season 20072008 . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product ( pharmaceutical product device ) . History hypersensitivity previous dose influenza vaccine Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . History allergic disease reaction likely exacerbate component vaccine ( ) . Acute disease time enrolment . Acute chronic , clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Administration immunoglobulins and/or blood product within three month precede administration study vaccine plan administration study period . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution . History chronic alcohol consumption and/or drug abuse . Any condition , opinion investigator , prevents subject participate study . History administration experimental/licensed vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Primary study</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>safety</keyword>
</DOC>